Berger Dietmar 4
4 · GILEAD SCIENCES, INC. · Filed Mar 12, 2025
Insider Transaction Report
Form 4
Berger Dietmar
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2025-03-10+8,530→ 57,505 total→ Common Stock (8,530 underlying) - Award
Non-qualified Stock Option (Right to Buy)
2025-03-10+37,710→ 37,710 totalExercise: $117.21Exp: 2035-03-10→ Common Stock (37,710 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
- [F3]The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.